Testing effectiveness (Phase 2)Study completedNCT00140348What this trial is testingDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineWho this might be right forProstate Cancer Cell Genesys 80
Early research (Phase 1)Study completedNCT03811652What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsWho this might be right forNon Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more MedImmune LLC 8
Testing effectiveness (Phase 2)Ended earlyNCT00906243What this trial is testingRNActive®-Derived Therapeutic VaccineWho this might be right forHormone Refractory Prostate Cancer University of Florida 6
Testing effectiveness (Phase 2)Looking for participantsNCT06001255What this trial is testingARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid TumorsWho this might be right forMetastasis Castration Resistant Prostate Cancer(mCRPC) Hansoh BioMedical R&D Company 120
Early research (Phase 1)Looking for participantsNCT06217822What this trial is testingFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forAdvanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression Bayer 198
Large-scale testing (Phase 3)Not Yet RecruitingNCT07200830What this trial is testingTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialWho this might be right forMetastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8 Alliance for Clinical Trials in Oncology 1,524
Early research (Phase 1)Looking for participantsNCT06784193What this trial is testingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more Olema Pharmaceuticals, Inc. 180
Early research (Phase 1)Active Not RecruitingNCT04397276What this trial is testingJNJ-70218902 in Participants With Advanced Stage Solid TumorsWho this might be right forNeoplasms Janssen Research & Development, LLC 82
Not applicableUnknownNCT02925702What this trial is testingPRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.Who this might be right forAdvanced Prostate CancerCastration ResistantRadium 223 Centro Nacional de Investigaciones Oncologicas CARLOS III 161
Testing effectiveness (Phase 2)Study completedNCT02797964What this trial is testingA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerWho this might be right forAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Sierra Oncology LLC - a GSK company 107
Testing effectiveness (Phase 2)Looking for participantsNCT05888532What this trial is testing64Cu-GRIP B in Patients With Advanced MalignanciesWho this might be right forProstate CancerRenal CancerUrethral Cancer+3 more Rahul Aggarwal 91
Testing effectiveness (Phase 2)Study completedNCT00077402What this trial is testingFenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer Cancer Therapeutics Research Group 50
Early research (Phase 1)Study completedNCT00327288What this trial is testingSafety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsWho this might be right forNon-small Cell Lung CancerBreast CancerProstate Cancer AmpliMed Corporation 34
Testing effectiveness (Phase 2)WithdrawnNCT02793219What this trial is testingProvenge Followed by Docetaxel in Castration-Resistant Prostate CancerWho this might be right forProstate Cancer The University of Texas Health Science Center, Houston
Large-scale testing (Phase 3)Looking for participantsNCT06551324What this trial is testingLearn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Who this might be right forMetastatic Castrate Resistant Prostate Cancer (mCRPC) Pfizer 600
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Testing effectiveness (Phase 2)Looking for participantsNCT05914116What this trial is testingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors DualityBio Inc. 862
Early research (Phase 1)Study completedNCT01692262What this trial is testingInvestigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.Who this might be right forMetastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,+3 more AstraZeneca 59
Not applicableEnded earlyNCT05301062What this trial is testingA Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone LevelsWho this might be right forMetastatic Castration-resistant Prostate CancerBone Metastases Bayer 8
Testing effectiveness (Phase 2)Study completedNCT04564027What this trial is testingA Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerWho this might be right forAdvanced Solid Tumours AstraZeneca 54